Introduction
Collectins are a family of proteins that contain a collagenlike region and a carbohydrate recognition domain (CRD) (Drickamer 1988) . Collectins are found in vertebrates including avians (Laursen et al. 1998 ). There are four groups of collectins: a mannan-binding protein (MBP) group, two lung surfactant groups of surfactant protein A (White et al. 1985) and surfactant protein D (SP-D) (Persson et al. 1989) , and a newly isolated group, collectin liver 1 (Ohtani et al. 1999 ) and collectin placenta 1 (CL-P1) (Ohtani et al. 2001) . Collectins are known to be involved in innate immunity through various mechanisms, for example, by activation of the complement pathway (Kawasaki et al. 1989) , by opsonization via collectin receptors (Schweinle et al. 1989; van Iwaarden et al. 1992) , and by amplification of phagocytosis by macrophages (Pikaar et al. 1995) . Interestingly, the type A scavenger receptor (SR-A) also contains a collagenlike domain (Kodama et al. 1990 ), which could bind and destruct pathogens by endocytosis and phagocytosis. In fact, recent data with SR-A1 knock-out mice (Suzuki et al.
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Recently, we cloned and characterized the human CL-P1 gene (hCL-P1), and found that it was a membrane-type collectin that functions as a scavenger receptor. The major tissue expression of the gene was endothelial cells but not in monocyte-macrophage lineage cells. We also found that CL-P1 was able to bind and phagocytose bacteria and yeast as well as oxidized low-density lipoprotein (Ohtani et al. 2001) . With these results, we hypothesized that this gene could play an important role in the human innate immunity system and/or atherosclerosis formation. To study this possibility, we are collecting human samples that are susceptible to infection, especially in childhood, and also samples from patients with atherosclerosis without lipid profile abnormalities. Haplotype association studies would be the best choice for this purpose. Here, we report the haplotype structure of the CL-P1 gene obtained from six singlenucleotide polymorphisms (SNPs) that were genotyped with 108 alleles in Japanese subjects.
Subjects and methods

Identification of SNPs
To identify useful SNPs in the gene region, we sequenced amplified DNAs derived from ten Japanese volunteers (20 alleles). Polymerase chain reaction (PCR) primers were chosen at approximately 500-bp intervals, with about an 80-bp overlap (Shinohara et al. 2001) . A total of 16 primer sets were designed based on the information obtained from a public genome database (AC022545, AP000925, AP001005, http://www.ncbi.nlm.nih.gov/) to amplify all 10 exons; 5Ј-flanking regions; and introns 1, 4, 6, 7, and 9. Other introns were sequenced in the regions near exon-intron boundaries. After amplification, a sequencing reaction was performed and analyzed on an ABI 310 genetic analyzer (PE Biosystems, Foster City, CA, USA). SNPs were detected by alignment of the sequencing data of ten individuals. To obtain SNPs in the 5Ј-upstream region, we analyzed 20 SNPs described in the publicly available SNP database of The SNP Consortium Ltd (TSC; http://snp.cshl.org/ index.html) with 20 Japanese alleles.
SNP genotyping
SNPs were genotyped using three PCR-based methods: single-strand conformational polymorphism (SSCP), SNaPshot, and sequencing. PCR was performed in a volume of 12.5 µl containing 20 ng genomic DNA, 75 mM Tris HCL (pH 8.8), 20 mM (NH 4 ) 2 SO 4 , 0.01% Tween 20, 1.5 mM MgCl2, 200 µM deoxyribonucleotide triphosphates (dNTPs), 10 pmol of each primer, and 0.25 units of Taq polymerase. PCR amplification was performed through 30 cycles of 94°C for 30 s, 49°-62°C for 30 s, and 72°C for 30 s, depending on the region analyzed, with a final extension step of 5 min at 72°C in a Gene Amp PCR9700 System (PE Biosystems). For SSCP analysis, each 2.5 µl of PCR products were mixed with formamide dye and heat denatured, and then applied to polyacrylamide gel electrophoresis. After electrophoresis, the gel was silver stained (Wako Pure Chemical, Tokyo, Japan) to detect polymorphic bands. A SNaPshot primer extension method was performed following the manufacturer's instructions (PE Biosystems). To obtain a purified template for SNaPshot and sequencing, we removed dNTPs and primers from amplified genomic DNA by means of ExoSAP-IT (USB, Cleveland, OH, USA). In the case of the SNaPshot method, reaction mixtures were electrophoresed on an ABI 310 genetic analyzer and data were analyzed with GeneScan software (PE Biosystems). For haplotype analysis, a total of 54 DNA samples (108 alleles) of healthy volunteers, recruited in our medical school, were genotyped. All of them were medical students and gave their informed consent. The Ethics Committee of Asahikawa Medical College approved this study.
Haplotype analysis
Estimation of haplotype frequency was performed by the maximum-likelihood method using SNPAlyze (DYNACOM, Yokohama, Japan, http://www. dynacom.co.jp/).
Results and discussion
By sequencing the CL-P1 gene region of ten Japanese volunteers (20 alleles), we identified five SNPs, two in intron 2 (SNP2, SNP3), one in exon 5 (SNP4), and two in exon 6 (SNP5, SNP6; Fig. 1, Table 1 ). In consideration of their importance in gene regulation, 20 SNPs were screened by sequencing the 5Ј-upstream region described in The SNP Consortium Ltd database. SNP1 was shown to be useful for our purposes. A total of six SNPs were used for genotyping and haplotype analysis. Genotype and allele frequencies of six SNPs and their location in the gene are shown in Table  1 . All genotype frequencies conformed to Hardy-Weinberg equilibrium. Genotyping of 54 individuals (108 alleles) revealed that all SNPs are quite common, the minor allele frequency being at least 29%.
Of six SNPs, three (SNP4-6) are located in the coding region, one silent mutation is located in exon 5 (SNP4: T267T), and two missense mutations are located in exon 6 (SNP5: S522P, SNP6: G606S; Table 1 ). As shown in Fig. 1 , the SNP5 in exon 6 is in the collagen-like domain that has a characteristic Gly-X-Y repetitive pattern, in which X and Y can be any amino acid but are frequently prolines or hydroxyprolines. SNP5, either serine or proline, located in the X position, could have some affect on the stability of collagen structure. In fact, in the MBP gene, which belongs to one of the collectin groups and is known to have a significant role in innate host immunity, three relatively common mutations in the homotrimeric region have been reported to be associated with invasive pneumococcal disease (Roy et al. 2002) . Although two of the three mutations, those in codons 54 and 57, located in the Gly position, the remaining mutation in codon 52 is located at the X position, which exchange the amino acid cysteine for arginine. In terms of SNP6 in exon 6, either glycine or serine is located in the neck domain. Hydrophobic amino acids in the neck domain contribute to form an alpha-helical coiled coil. A coiled-coil structure can be recognized by its characteristic heptad repeat pattern a-b-c-d-e-f-g, in which "a" and "d" are hydrophobic residues. Each alpha-helix interacts with a neighboring CRD (Sheriff et al. 1994) . Human MBP and SP-D have such heptad repeats in the neck domain (Zhang et al. 2001) . However, in the case of hCL-P1, the neck domain of 17 amino acid residues does not have a characteristic heptad structure. Even so, both collagen-like domain and CRD have a collaborative role in recognizing pathogens, and an amino acid alteration in the neck domain might still have some influence.
The result of linkage disequilibrium (LD) analysis is summarized in Table 2 . Among the SNPs, only SNP4 and SNP5 showed significant LD (r 2 ϭ 0.823). Haplotype frequencies among 108 alleles were calculated (Table 3) . The top eight haplotypes with frequencies over 5% accounted for 67% of all haplotypes.
CL-P1 is a member of the collectin family, which is considered to play significant roles in innate immunity. Classical collectins are soluble, but CL-P1 is membrane bound. CL-P1 might bind and control not only bacteria and yeasts, but also modified LDLs in the vascular space. The collagenlike domains in human and mouse CL-P1, which have the highest identity (96%) described to date, may play the most important role in these biological functions (Ohtani et al. 2001) .
In conclusion, these six polymorphisms, their haplotype, and the state of LD will the useful for investigation of a possible relationship between genetic variation at the SNP1  SNP2  SNP3  SNP4  SNP5  SNP6  TG  AG  GA  TC  CT  GA  Frequency   G  G  A  C  C  G  0.155  T  G  G  T  T  G human CL-P1 locus and human diseases, especially in association studies between specific polymorphisms and susceptibility to innate immunity disease or atherosclerosis.
